Document is current

Article History

Received: 21 June 2023

Revised: 21 January 2024

Accepted: 1 February 2024

First Online: 11 March 2024

Declarations

:

: The scientific guarantor of this publication is Erik R. Ranschaert.

: The authors of this manuscript declare relationships with the following companies:E.R.R.: Member of European Radiology Advisory Editorial Board (European Society of Medical Imaging Informatics), medical advisor Oxipit.ai, Contextflow.com, Quibim.com, Osimis.io; N.R.: chief medical officer Oxipit; J.J.V.: grant to institution from Qure.ai; consulting fees from Tegus; payment to institution for lectures from Roche; travel grant from Qure.ai; participation on a data safety monitoring board or advisory board from Contextflow, Noaber Foundation, and NLC Ventures; leadership or fiduciary role on the steering committee of the PINPOINT Project (payment to institution from AstraZeneca) and RSNA Common Data Elements Steering Committee (unpaid); phantom shares in Contextflow and Quibim; R.G.H.B.T.: Member of European Radiology Scientific Editorial Board (Oncology). The authors who are members of the editorial boards for European Radiology have not taken part in the review or selection process of this article. The remaining authors declare no relationships with any companies, whose products or services may be related to the subject matter of the article.

: One of the authors (Renee Menezes) has significant statistical expertise.

: Written informed consent was waived by the Institutional Review Board or ethics committee due to the retrospective nature of the study.

: The study was approved by the ethics committee of Elisabeth-TweeSteden Hospital (NW2021-57) and the Institutional Review Board of the Netherlands Cancer Institute (IRBd19163).

: No study subjects have been previously reported.

: • retrospective• observational study• multicentre study